Technical Analysis for CLSN - Celsion Corporation

Grade Last Price % Change Price Change
grade F 1.1693 -7.20% -0.09
CLSN closed up 16.67 percent on Tuesday, August 4, 2020, on 1.88 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical CLSN trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup -7.20%
Pocket Pivot Bullish Swing Setup -7.20%
Wide Bands Range Expansion -7.20%
Oversold Stochastic Weakness -7.20%
MACD Bullish Signal Line Cross Bullish 8.27%
Narrow Range Bar Range Contraction 8.27%
Wide Bands Range Expansion 8.27%
Oversold Stochastic Weakness 8.27%
Narrow Range Bar Range Contraction 6.30%
Inside Day Range Contraction 6.30%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company develops ThermoDox, a liposomal encapsulation of doxorubicin, which is under Phase III clinical trial for primary liver cancer; under phase II clinical trial for colorectal liver metastasis; and under phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. for ThermoDox; and a joint research agreement with Royal Philips Electronics to evaluate the combination of Philips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat various cancers. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
Medicine Cancer Clinical Medicine Cancers Chemotherapy Drug Development Ultrasound Antineoplastic Drugs Hepatology Hepatocellular Carcinoma Doxorubicin High Intensity Focused Ultrasound Anthracyclines Teratogens

Is CLSN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.5
52 Week Low 0.6865
Average Volume 4,406,974
200-Day Moving Average 1.71
50-Day Moving Average 2.76
20-Day Moving Average 1.52
10-Day Moving Average 1.14
Average True Range 0.29
ADX 25.05
+DI 28.52
-DI 30.93
Chandelier Exit (Long, 3 ATRs ) 3.56
Chandelier Exit (Short, 3 ATRs ) 1.90
Upper Bollinger Band 3.31
Lower Bollinger Band -0.28
Percent B (%b) 0.43
BandWidth 236.43
MACD Line -0.51
MACD Signal Line -0.55
MACD Histogram 0.036
Fundamentals Value
Market Cap 10.52 Million
Num Shares 8.35 Million
EPS -5.58
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 47.77
Price-to-Book 2.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.64
Resistance 3 (R3) 1.62 1.47 1.57
Resistance 2 (R2) 1.47 1.38 1.48 1.55
Resistance 1 (R1) 1.37 1.32 1.42 1.39 1.53
Pivot Point 1.22 1.22 1.25 1.23 1.22
Support 1 (S1) 1.12 1.13 1.17 1.14 0.99
Support 2 (S2) 0.97 1.07 0.98 0.97
Support 3 (S3) 0.87 0.97 0.95
Support 4 (S4) 0.89